Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
202
天
Cellular adhesion-dependent 3D morphogenesis indicating brain tumor aggressiveness and chemosensitivity in spherical cavity culture
作者
Thuy Huynh; Jieun Kim; Sarnai Amartumur; Inhee Choi; Ji Yeoun Lee; Luke P. Lee; Chaejeong Heo展开收起
作者单位
1. Department of Biophysics, Institute for Quantum Biophysics (IQB), Sungkyunkwan University, Suwon, Republic of Korea; 2. Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul, Republic of Korea; 3. Department of Life Science, Department of Chemistry, University of Seoul, Seoul, Republic of Korea; 4. Division of Pediatric Neurosurgery, Seoul National University Children’s Hospital, Seoul, Republic of Korea; 5. Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, USA; 6. Korea Biomedical Institute for Global Health Research and Technology (K-BIGHEART), Pohang University of Science and Technology (POSTECH), Gyeongbuk, Republic of Korea展开收起
151
天
The spatial and multi-omic landscape of Down syndrome leukemogenesis: moving beyond cellular heterogeneity
作者
Edoardo Peroni; Rosario Amato; Martina Bado; Mosè Favarato; Antonio Rosato展开收起
作者单位
1. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy; 2. UOC Genetica Medica, Azienda Ospedaliera Universitaria Dulbecco, Università Magna Graecia, Catanzaro, Italy; 3. Lab. Immuno-Genetica, Dpt. Scienze della Salute, Università degli Studi “Magna Graecia” di Catanzaro, Catanzaro, Italy; 4. Dipartimento di Direzione Medica del Presidio Ospedaliero di Mestre, UOSD Genetica e Citogenetica, Venice, Italy; 5. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy展开收起
62
天
Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting
作者
Tiantian Zhang; Heng Jiang; Delong Liu展开收起
作者单位
1. Department of Internal Medicine, University of Central Florida, Pensacola, USA; 2. Chinese American Hematologist and Oncologist Network (CAHON), Milwaukee, USA; 3. Division of Hematology and Oncology, Department of Internal Medicine, Westchester Medical Center/New York Medical College, Valhalla, USA展开收起
146
天
Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs
作者
Edoardo Peroni; Marco Pizzi; Marco Basso; Alessandro Atanasio; Elisabetta Calistri; Michele Gottardi; Antonio Rosato展开收起
作者单位
1. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy; 2. Department of Medicine-DIMED, Surgical Pathology and Cytopathology Unit, Padua University Hospital, Padua, Italy; 3. Pharmacy, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; 4. Onco-Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy; 5. Department of Surgery Oncology and Gastroenterology, University of Padova, Padova, Italy展开收起
67
天
Arsenic trioxide promotes a glue‑like interaction to drive STUB1-mediated NPM-ALK degradation in ALK + ALCL
作者
Guiming Li; Jun Wang; Shiguang Ye; Lixin Zhou; Yanli Sun; Bowen Li; Yunshuo Zhao; Yi Ding; Yu Zeng; Bin Xue; Guangming Wang; Fangce Wang; Xiu Luo; Aibin Liang; Ellen L. Weisberg; Wenjun Zhang; Wenchao Lu; Jing Yang展开收起
作者单位
1. Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China; 2. Lingang Laboratory, Shanghai, China; 3. Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; 4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 5. Department of Medicine, Harvard Medical School, Boston, USA展开收起
61
天
Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting
作者
Haibo Yu; Ting Shi; Hong-Hu Zhu展开收起
作者单位
1. Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; 2. Chinese Institutes for Medical Research, Beijing, China; 3. Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天